| Literature DB >> 32218315 |
Youssef Hamway1, Karin Taxauer1, Kristof Moonens2,3, Victoria Neumeyer1, Wolfgang Fischer4, Verena Schmitt5, Bernhard B Singer5, Han Remaut2,3, Markus Gerhard1,6, Raquel Mejías-Luque1,6.
Abstract
Attachment to the host gastric mucosa is a key step in Helicobacter pylori infection. Recently, a novel adhesin, HopQ, was shown to bind distinct host CEACAM proteins-an interaction that was found to be essential for the translocation of CagA, a key virulence factor of H. pylori. The HopQ-CEACAM1 co-crystal structure revealed a binding mode dependent on loops in HopQ that are clasped by disulfide bonds. In this study, we investigated the importance of these cysteine residues for CEACAM1 engagement by H. pylori. We observed a loss of CEACAM1 binding and CagA translocation upon disruption of the disulfide bond in loop CL1 (connecting C103 to C132 in HopQ). Deletion of the Dsb-like oxidoreductase HP0231 did not affect cell surface expression of HopQ or alter the interaction of H. pylori with target cells. Although HP0231 deletion was previously described to impede CagA translocation, our results indicate that this occurs through a HopQ-independent mechanism. Together, our results open up new avenues to therapeutically target the HopQ-CEACAM1 interaction and reduce the burden of pathogenic H. pylori.Entities:
Keywords: CEACAM1; CagA delivery; Dsb-like proteins; Helicobacter pylori; HopQ; bacterial adhesion; host-pathogen interactions
Year: 2020 PMID: 32218315 PMCID: PMC7232459 DOI: 10.3390/microorganisms8040465
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Figure 1Disulfides are critical for HopQ stability. Thermal shift (Thermofluor) assay measuring the thermal unfolding of HopQ in the presence of a range of DTT concentrations. Error bars show S.D.
Figure 2An intact CL1 disulfide in HopQ is crucial for CEACAM1 binding. (a) Western blot showing pull down pattern of recombinant CEACAM1 using the wild type H. pylori strain G27, G27 ∆hopQ, or G27 ∆hopQ strains that are complemented with either wild type or different mutant hopQ alleles. (b) HopQ protein levels detected by Western blot in outer membrane extracts of different H. pylori strains. HpaA and gGT were used as positive and negative controls for the membrane preparation, respectively. (c) and (d) Flow cytometry cell-binding assay. Bar graph showing the percentage of CHO cells (carrying a vector control or expressing CEACAM1-4L) (c) or MKN28 cells (d) bound by fluorescently labelled H. pylori from panel (a). ‘-’ denotes cells with no bacteria added. (e) Confocal microscopy and quantification of fluorescently labeled G27, G27 ∆hopQ, or G27 ∆hopQ strains complemented with either wild type or different mutant hopQ alleles binding to CHO-CEACAM1-4L (CC1) cells. Scale bar 25 µm. Magnification = 63×. (f) Flow cytometry H. pylori binding assay. Bar graph showing the percentage of H. pylori binding to CEACAM-GFP. ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001.
Figure 3Deletion of HP0231 does not influence HopQ expression, stability or its CEACAM1 binding capacity. (a) Western blot of different H. pylori strains, probed with anti-HopQ and anti-HP0231 serum. (b) Pulldown of recombinant CEACAM1-Fc by several H. pylori strains. (c) Flow cytometry binding assay of same H. pylori strains to CEACAM1-deficient MKN28 cells, CEACAM1-4L-transfected MKN28 cells, CHO-CEACAM1-4L (CC1) cells, and AGS cells. ‘-’ denotes cells with no bacteria added. (d) Immunofluorescence microscopy and quantification of G27 wild type, ∆hopQ and ∆hp0231 H. pylori strains binding to MKN28-CEACAM1-4L cells. Scale bar 25 µm. HPF, high-power field. * p ≤ 0.05, **p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001.
Figure 4HopQ CL1 mutants are unable to translocate CagA. CagA, p-CagA, and GAPDH protein levels detected by Western blot in lysates of MKN28-CEACAM1-4L cells infected with different G27 (a) or P12 (b) H. pylori strains.